Liquid Biopsy Market Analysis and Key Insights 2023, Competitor Analysis - Janssen Diagnostics, Qiagen, Rarecells SAS, Silicon Biosystems, Myriad Genetics, Natera, Personal Genome Diagnostics, Sysmex Inostics, Trovagene, Exosome Diagnostics, HansaBiomed O

Global Liquid Biopsy Market Overview:

This technology of liquid biopsy has enormous diagnostic and treatment implications for oncology and it is believed to transform clinical practice. A liquid biopsy may capture the entire heterogeneity of the disease. This methodology is advantageous over tissue biopsies as monitoring of tumor genomic can be done by taking serial samples.

Request for Sample @ https://marketdataforecast.com/market-reports/liquid-biopsy-market-950/request-sample

Global Liquid Biopsy Market Size:

According to Market Data Forecast, The Global Liquid Biopsy market is expected to increase at a CAGR of 24.3% in the forecast period of 2018-2023 and reach a value of USD 3722.94 million by 2023 from USD 1166.72 million in 2018.

Foremost drivers for the liquid biopsy market include. Liquid biopsies are adopted due to factors such as tolerability and patient convenience. Tissue biopsies cannot be done for few non-small cell lung cancers and liquid biopsy procedures are replacing tissue diagnosis procedures in such cases. Liquid biopsy research process involves a large amount of money and frequent clinical trials which is acting as a restraint for the market growth.

Market Segmentation:

The liquid biopsy market is mainly segmented by types of cancer into Lung Cancer, Pancreatic Cancer, Leukemia and Other Visceral Cancers. By Diagnostic approach, they can be classified as Circulating Tumor cells (CTC), Circulating Tumor DNA (ctDNA), RNA in exosomes and Extra-Cellular Vesicles. Based on end users, the market is segmented into reference laboratories, hospital/physician laboratories, academic and research centers, and other end users. The market is bifurcated into blood, urine, plasma, saliva and Cerebrospinal fluid based upon sample type. CTCs (Circulating Tumor cells), the first such entities on the liquid biopsy scene, have accounted for a large share in the market. Cancer institute is the largest end user segment in terms of revenues and is expected to create substantial opportunity in global liquid biopsy market over the forecast period.

Browse Report Brief and TOC @ https://marketdataforecast.com/market-reports/liquid-biopsy-market-950/

Geographical Analysis:

Geographically the market is segmented into North America (U.S.A. and Canada), Europe (U.K., Germany, Italy, France, and Spain), Asia-Pacific (India, China, Australia, South Korea and Japan), Latin America (Mexico, Argentina and Brazil), Middle east and Africa. All major action in the field of liquid biopsy is expected to emerge from North America and Europe region over the forecast period. However, increasing funding for private public partnerships in field of cancer research is expected to fuel the Asia-Pacific Market.

Major Key Players Dominating the Liquid Biopsy Market are:

• Janssen Diagnostics
• Qiagen
• Rare cells SAS
• Silicon Biosystems
• SRI International
• Myriad Genetics
• Natera
• Personal Genome Diagnostics
• Sysmex Inostics
• Trovagene
• Exosome Diagnostics
• Exosome Sciences
• HansaBiomed OU

Buy Now @ https://marketdataforecast.com/cart/buy-now/liquid-biopsy-market-950/

Reasons to Purchase Liquid Biopsy Market Report:

• Current and future Liquid Biopsy Market Outlook in the developed and emerging markets
• Analyzing various perspectives of the market with the help of Porter’s five forces analysis
• The segment that is expected to dominate the market
• Regions that are expected to witness the fastest growth during the forecast period
• Identify the latest developments, market shares, and strategies employed by the major market players
• 3-month analyst support, along with the Market Estimate sheet in excel

Customize Report @ https://marketdataforecast.com/market-reports/liquid-biopsy-market-950/customize-report

About Us
Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients.

For more information:
Abhishek Shukla
Sales Manager at Market Data Forecast
Email: abhishek@marketdataforecast.com
Tel: +1-888-702-9626
Website: www.marketdataforecast.com

This release was published on openPR.